A clinical trial to study the effects of multi-modal interventions on quality of life, symptom burdens and self efficacy among ovarian cancer patients
Phase 3
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2024/07/070768
- Lead Sponsor
- Chaitali Biswas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed Ovarian cancer patients
1. With any stage from II, III, and IV.
2. Eastern Cooperative Oncology group (ECOG) performance status within 2.
3. Planned for initial treatment either with chemotherapy or Surgery.
4. Able to understand, read, and write Bengali or Hindi or English.
5. Who are willing to be a part of the study
Exclusion Criteria
Ovarian cancer patients who are
1. Critically ill.
2. ECOG performance status more than 2.
3. Diagnosed as a relapse of ovarian cancer patients.
4. under palliative care
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of multi-modal interventions on Quality of life, Symptom management and self-efficacy among ovarian cancer pateintsTimepoint: Quality of life, Symptom burdens, and self-efficacy as the outcome of the multi-modal intervention will be assessed at baseline, 3 month, 6 month and 9 month for both experimental arm and control arm
- Secondary Outcome Measures
Name Time Method To encourage and motivate the individual Ovarian cancer patients under study to adapt the intervention in their daily life and thus to improve the self-efficacy and self management of symptoms and health related quality of lifeTimepoint: at 9 months after the study as well as continue throughout the survival period